23andMe Investor Presentation Deck
Pharmaceutical
Industry
7
years average
time-to-IND¹
~90%
failure rate²
NATURE GENETICS PUBLICATION
23andMe
~4
years to IND
with CD96
drug
Targets
with genetic
evidence have
historically had
a higher
success
rate³
The support of human genetic evidence
for approved drug indications
Nelson et. al 2015
¹ IND = Investigational New Drug Application. fdareview.org, "The Drug Development and Approval Process" (2020).
2 Probability of success for a drug to be approved is estimated to be <12%. PhRMA, "Biopharmaceutical Research & Development:
The Process Behind New Medicines" (2015).
3 Nature Genetics Publication, "The support of human genetic evidence for approved drug indications" (2015).
Potential to More
Efficiently Develop
Novel Therapeutics
by "Power, Need,
and Speed"
28View entire presentation